Lessons From an Analysis of Newborn Hearing Screening Data for Children With Cochlear Implants

Area of Science:

• Audiology
• Genetics
• Pediatrics

Background:

• Newborn hearing screening (NHS) aims for early detection of hearing loss.
• Limitations exist in current NHS protocols, potentially leading to delayed diagnosis and intervention.
• Genetic factors, such as SLC26A4 mutations, are significant causes of congenital hearing loss.

Purpose of the Study:

• To identify limitations in current newborn hearing screening (NHS) programs.
• To provide recommendations for improved NHS protocols.
• To analyze the impact of NHS results on cochlear implant (CI) outcomes and language development.

Main Methods:

• Retrospective analysis of 185 children who received cochlear implants (CIs) at ≤5 years of age.
• Review of NHS data, screening tools, age of diagnosis, hearing thresholds, causes of hearing loss, age of CI insertion, audiogram findings, and language development.
• Statistical comparison between children who passed NHS and those referred for further evaluation.

Main Results:

• 22% of children passed NHS, but 78% were later diagnosed with hearing loss.
• Children who passed NHS had hearing loss confirmed significantly later than referred children.
• The NHS-pass group received CIs later, and those with SLC26A4 mutations showed significantly lower language development.

Conclusions:

• Parents require thorough counseling on NHS results, emphasizing that a negative screen does not preclude later-onset hearing loss.
• Genetic testing for SLC26A4 mutations is recommended in regions with high prevalence.
• Improved NHS protocols and genetic screening can enhance early intervention for hearing loss.